Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riboflavin in moderate to severe plaque psoriasis
NCT02622386Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Aug 2016
- Primary completion
- Apr 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of riboflavin in plaque psoriasis, sponsored by University of Michigan. Started Aug 2016; status: completed.
02
Drugs
riboflavin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02622386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02622386.